companydata.dkcompanydata.dk

UNION therapeutics A/S: Financial statements 2017

CVR: 33963750

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

UNION therapeutics A/S (CVR 33963750) has filed annual accounts for 2017. In 2017, the company reported revenue of USD 315,394 and a net result of USD -5,396,630 compared with USD -485,441 the year before. That is a decrease of 56.7% compared with the year before. The profit margin was -1,711.1%. Equity in the 2017 report amounted to USD 1,944,103. The solvency ratio was 52.3%.

Revenue
USD 315,394
Profit/Loss
USD -5,396,630
Equity
USD 1,944,103
Total Assets
USD 3,716,557

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017315K USD--5.4M USD1.9M USD-
2016729K USD-343K USD-485K USD-195K USD-
2015691K USD-154K USD-224K USD-71K USD-
2014-3.1M578K988K-
2013-1.2M359K410K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on UNION therapeutics A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

Stig Løkke Pedersen joins the board of UNION therapeutics A/SJun 23, 2017

As of June 23, 2017, Stig Løkke Pedersen has joined the board of directors of UNION therapeutics A/S.

Ole Skov joins the board of UNION therapeutics A/SJun 23, 2017

As of June 23, 2017, Ole Skov has joined the board of directors of UNION therapeutics A/S.

Jutta Monika Heim joins the board of UNION therapeutics A/SJun 23, 2017

As of June 23, 2017, Jutta Monika Heim has joined the board of directors of UNION therapeutics A/S.

Astrid Sommer leaves the board of UNION therapeutics A/SJun 23, 2017

As of June 23, 2017, Astrid Sommer has left the board of directors of UNION therapeutics A/S.

Anne Katrine Toft-Kehler leaves the board of UNION therapeutics A/SJun 23, 2017

As of June 23, 2017, Anne Katrine Toft-Kehler has left the board of directors of UNION therapeutics A/S.

Ole Skov leaves the board of UNION therapeutics A/SJun 22, 2017

As of June 22, 2017, Ole Skov has left the board of directors of UNION therapeutics A/S.

UNION therapeutics A/S: The 2016 annual report is outJun 6, 2017

UNION therapeutics A/S has published its annual report for 2016. Revenue came to DKK 728,695, and the net result was DKK -485,441.

Ole Skov joins the board of UNION therapeutics A/SJun 1, 2017

As of June 1, 2017, Ole Skov has joined the board of directors of UNION therapeutics A/S.

Rasmus Vendler Toft-Kehler joins UNION therapeutics A/S as directorJun 1, 2017

As of June 1, 2017, Rasmus Vendler Toft-Kehler is registered as director of UNION therapeutics A/S.

Rasmus Vendler Toft-Kehler steps down as adm. dir. of UNION therapeutics A/SMay 31, 2017

As of May 31, 2017, Rasmus Vendler Toft-Kehler has stepped down as adm. dir. of UNION therapeutics A/S.

About UNION therapeutics A/S

UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.

Source: annual report 2025, Danish Business Authority